223 related articles for article (PubMed ID: 29674338)
21. Office blood pressure versus ambulatory blood pressure measurement in childhood obesity.
van der Heijden LB; Groothoff JW; Feskens EJ; Janse AJ
BMC Pediatr; 2023 Apr; 23(1):205. PubMed ID: 37120521
[TBL] [Abstract][Full Text] [Related]
22. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.
Li Kam Wa TC; Macnicol AM; Watson ML
Nephrol Dial Transplant; 1997 Oct; 12(10):2075-80. PubMed ID: 9351068
[TBL] [Abstract][Full Text] [Related]
24. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
[TBL] [Abstract][Full Text] [Related]
25. Severe parental phenotype associates with hypertension in children with ADPKD.
Demoulin N; Van Regemorter E; Dahan K; Hougardy C; Morelle J; Gillion V; Ranguelov N; Godefroid N
Pediatr Nephrol; 2023 Aug; 38(8):2733-2740. PubMed ID: 36645493
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
27. Prospective change in renal volume and function in children with ADPKD.
Cadnapaphornchai MA; McFann K; Strain JD; Masoumi A; Schrier RW
Clin J Am Soc Nephrol; 2009 Apr; 4(4):820-9. PubMed ID: 19346430
[TBL] [Abstract][Full Text] [Related]
28. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
Nowak KL; Wang W; Farmer-Bailey H; Gitomer B; Malaczewski M; Klawitter J; Jovanovich A; Chonchol M
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1493-1501. PubMed ID: 30228110
[TBL] [Abstract][Full Text] [Related]
29. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
[TBL] [Abstract][Full Text] [Related]
30. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
Karava V; Benzouid C; Hogan J; Dossier C; Denjean AP; Deschênes G
Pediatr Nephrol; 2018 Sep; 33(9):1513-1521. PubMed ID: 29774463
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
[TBL] [Abstract][Full Text] [Related]
32. Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy.
Yildiz A; Sag S; Gul CB; Güllülü S; Can FE; Bedir Ö; Aydin MF; Oruç A; Demirel S; Akgür S; Güllülü M; Ersoy A
Ren Fail; 2021 Dec; 43(1):223-230. PubMed ID: 33478355
[TBL] [Abstract][Full Text] [Related]
33. Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.
Seeman T; Jansky P; Filip F; Bláhová K; Jaroš A
Pediatr Nephrol; 2021 Nov; 36(11):3717-3723. PubMed ID: 34008126
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease.
de Almeida EA; de Oliveira EI; Lopes JA; Almeida AG; Lopes MG; Prata MM
Rev Port Cardiol; 2007 Mar; 26(3):235-43. PubMed ID: 17549981
[TBL] [Abstract][Full Text] [Related]
35. Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
Kario K; Hoshide S; Mizuno H; Kabutoya T; Nishizawa M; Yoshida T; Abe H; Katsuya T; Fujita Y; Okazaki O; Yano Y; Tomitani N; Kanegae H;
Circulation; 2020 Nov; 142(19):1810-1820. PubMed ID: 33131317
[TBL] [Abstract][Full Text] [Related]
36. Subclinical Target Organ Damage in a Sample of Children with Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.
Romano S; Marcon D; Branz L; Tagetti A; Monamì G; Giontella A; Malesani F; Pecoraro L; Minuz P; Brugnara M; Fava C
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893495
[No Abstract] [Full Text] [Related]
37. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
Handa SP
Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
[TBL] [Abstract][Full Text] [Related]
38. [Effects of nighttime and daytime interval definition on blood pressure and dipping in patients referred for ambulatory blood pressure measurement].
Muller ME; Bochud M; Pruijm M; Iglesias K; Burnier M; Wuerzner G
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):193-7. PubMed ID: 22683138
[TBL] [Abstract][Full Text] [Related]
39. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
40. Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD).
Dudley J; Winyard P; Marlais M; Cuthell O; Harris T; Chong J; Sayer J; Gale DP; Moore L; Turner K; Burrows S; Sandford R
BMC Nephrol; 2019 Apr; 20(1):148. PubMed ID: 31039757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
